Pieris Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 May 23 | BuyUS$8,500 | Christopher Kiritsy | Individual | 125 | US$68.00 | |
11 May 23 | BuyUS$13,145,407 | BVF Partners L.P. | Company | 194,119.29 | US$68.80 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 101 | 0.00817% |
Individual Insiders | 816 | 0.066% |
Public Companies | 91,130 | 7.37% |
Institutions | 102,213 | 8.27% |
Hedge Funds | 379,821 | 30.7% |
General Public | 662,606 | 53.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
257,623 | US$2.9m | 0% | 0.07% | |||
122,198 | US$1.4m | 0% | 0.28% | |||
46,327 | US$516.1k | 0% | no data | |||
44,803 | US$499.1k | 0% | no data | |||
14,873 | US$165.7k | 122% | no data | |||
13,312 | US$148.3k | 179% | no data | |||
12,971 | US$144.5k | 0% | no data | |||
12,029 | US$134.0k | 0% | no data | |||
11,342 | US$126.4k | -12.4% | no data | |||
9,518 | US$106.0k | 0% | no data | |||
9,375 | US$104.4k | 15.5% | 0.09% | |||
3,044 | US$33.9k | 76.8% | no data | |||
2,785 | US$31.0k | 0% | no data | |||
2,083 | US$23.2k | -26.1% | no data | |||
1,750 | US$19.5k | 0% | no data | |||
1,377 | US$15.3k | 0% | no data | |||
1,287 | US$14.3k | 0% | no data | |||
1,125 | US$12.5k | 0% | no data | |||
1,107 | US$12.3k | 0% | no data | |||
511 | US$5.7k | -3.4% | no data | |||
496 | US$5.5k | 0% | no data | |||
432 | US$4.8k | 41.6% | no data | |||
375 | US$4.2k | 0% | no data | |||
375 | US$4.2k | 0% | no data | |||
282 | US$3.1k | 0% | no data |